Immunity, Labelling and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Immunity

Labelling

White Paper

Africa’s growing vaccine capacity

Quality Matters

FEBRUARY 9, 2023

Of these countries, five have end-to-end manufacturing capacity, and three can import, label, or pack vaccines, a process known as fill and finish. Guide short-term and long-term objectives of national immunization plans and support sustainable expansion of manufacturing to reduce dependence on donor funding.

Vaccines

Vaccines Immunity Immunization Labelling

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Pharmaceutical Technology

MARCH 21, 2023

A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. FDA and EMA decisions In January, the European Commission (EC) approved Roche’s Xofluza (baloxavir marboxil) to prevent and treat influenza in children ages one year and older.

Packaging

Packaging Vaccines Labelling Communication

Pharmacist Digest

Africa’s growing vaccine capacity

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Stay Connected